Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma

被引：5
|
作者：
Coiffier, B [1 ]
Salles, G [1 ]
机构：
[1] Ctr Hosp Lyon Sud, Dept Hematol, F-69495 Pierre Benite, France
来源：
BLOOD | 2004年 / 104卷 / 05期
关键词：
D O I：
10.1182/blood-2004-04-1266
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1584 / 1585
页数：2
相关论文
共 50 条
  • [31] Disease Characteristics, Patterns of Care, and Survival in Very Elderly Patients with Diffuse Large B-Cell Lymphoma
    Williams, Jessica N.
    Rai, Ashish
    Lipscomb, Joseph
    Koff, Jean L.
    Nastoupil, Loretta J.
    Flowers, Christopher R.
    BLOOD, 2014, 124 (21)
  • [32] Immunochemotherapy RCHOP in patients with diffuse large B-cell lymphoma over 75 year old.
    Paszkiewicz-Kozik, Ewa
    Romejko-Jarosinska, Joanna
    Osowiecki, Michal
    Becht, Rafal
    Swierkowska-Czeneszew, Monika
    Domanska-Czyz, Katarzyna
    Ostrowska, Beata
    Poplawska, Lidia
    Rymkiewicz, Grzegorz
    Walewski, Jan Andrzej
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [33] Diffuse large B-cell lymphoma - Molecular heterogeneity of diffuse large B-cell lymphoma
    Gascoyne, RD
    HEMATOLOGY JOURNAL, 2004, 5 : S144 - S148
  • [34] Survivin expression in patients with newly diagnosed nodal diffuse large B-cell lymphoma treated with immunochemotherapy
    Cemerikic-Martinovic, V.
    Markovic, O.
    Marisavljevic, D.
    Martinovic, T.
    Andjelkovic, N.
    Djurdjevic, P.
    VIRCHOWS ARCHIV, 2012, 461 : S196 - S197
  • [35] TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma
    Harris, Will
    Bataillard, Edward J.
    Choi, Yoonha
    El-Galaly, Tarec C.
    Cuchelkar, Vaikunth
    Henneges, Carsten
    Kwan, Antonia
    Schneider, Daniel J.
    Paulson, Joseph N.
    Nielsen, Tina G.
    JCO CLINICAL CANCER INFORMATICS, 2022, 6
  • [36] Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches
    Allen, Pamela
    CURRENT ONCOLOGY REPORTS, 2020, 22 (11)
  • [37] Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches
    Pamela Allen
    Current Oncology Reports, 2020, 22
  • [38] IMMUNOCHEMOTHERAPY-INDUCED CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA: RESPONSE TO ZOFENOPRIL
    Samura, B.
    HAEMATOLOGICA, 2013, 98 : 650 - 651
  • [39] Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with Immunochemotherapy
    Klanova, Magdalena
    Oestergaard, Mikkel Z.
    Trneny, Marek
    Hiddemann, Wolfgang
    Marcus, Robert
    Sehn, Laurie H.
    Vitolo, Umberto
    Bazeos, Alexandra
    Goede, Valentin
    Zeuner, Harald
    Knapp, Andrea
    Sahin, Deniz
    Spielewoy, Nathalie
    Bolen, Christopher R.
    Cardona, Andres
    Klein, Christian
    Venstrom, Jeffrey M.
    Nielsen, Tina
    Fingerle-Rowson, Guenter
    CLINICAL CANCER RESEARCH, 2019, 25 (15) : 4634 - 4643
  • [40] The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
    Isaksen, Kathrine T.
    Galleberg, Renate
    Mastroianni, Maria Adele
    Rinde, Marit
    Rusten, Leiv Sindre
    Barzenje, Dlawer
    Ramslien, Frode
    Fluge, Oystein
    Slaaen, Marit
    Meyer, Peter
    Liestol, Knut
    Smeland, Erlend B.
    Lingjaerde, Ole Christian
    Holte, Harald
    Brodtkorb, Marianne
    REVISTA CHILENA DE LITERATURA, 2023, (108): : 2454 - 2466
12345